ATACICEPT IN IGA NEPHROPATHY: CONTINUED PROTECTIVE TITERS TO DIPHTHERIA AND TETANUS AND BALANCED INFECTIONS VS PLACEBO WITH A FOCUS ON COVID-19

https://storage.unitedwebnetwork.com/files/1099/ae87736974bf77c29ef5e8a0a5c53069.pdf
ATACICEPT IN IGA NEPHROPATHY: CONTINUED PROTECTIVE TITERS TO DIPHTHERIA AND TETANUS AND BALANCED INFECTIONS VS PLACEBO WITH A FOCUS ON COVID-19
Jonathan
Barratt
Bart Maes bart.maes@azdelta.be AZ Delta Nephrology Roeselare
Rubeen Israni rubeen.israni@veratx.com Vera Therapeutics Clinical Development Brisbane
Xuelian Wei xuelian.wei@veratx.com Vera Therapeutics Biostatistics Brisbane
Vladimir Tesar vladimir.tesar@vfn.cz Charles University Nephrology Prague
Gerald Appel GBA2@cumc.columbia.edu Columbia University Nephrology New York
Yusuke Suzuki yusuke@juntendo.ac.jp Juntendo University Nephrology Tokyo
Celia Lin celia.lin@veratx.com Vera Therapeutics Medical Brisbane
Richard Lafayette czar@stanford.edu Stanford University Nephrology Stanford